Related Scientific Literature
- Monitoring antibody response following SARS-CoV-2 infection: Diagnostic efficiency of four automated immunoassays
- Diagnostics for SARS-CoV-2 detection: A comprehensive review of the FDA-EUA COVID-19 testing landscape
- Comparative Evaluation of Three Serologic Assays for the Identification of SARS-CoV-2 Antibodies
- Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity
- RT-PCR testing to detect a COVID-19 outbreak in Austria: rapid, accurate and early diagnosis in primary care (The REAP study)
- Correlation of ELISA based with random access serologic immunoassays for identifying adaptive immune response to SARS-CoV-2
- EVALUATION OF THE ROCHE ELECSYS ANTI-SARS-COV-2 ASSAY
- Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2
- Analytical and Clinical Evaluation of the Automated Elecsys Anti-SARS-CoV-2 Antibody Assay on the Roche cobas e602 Analyzer
- Current and Perspective Diagnostic Techniques for COVID-19
- Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges
- Comparison of test performance of commercial anti-SARS-CoV-2 immunoassays in serum and plasma samples
- Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies
- COVID-19 Serological Tests: How Well Do They Actually Perform?
- In vitro diagnostics of coronavirus disease 2019: Technologies and application
- Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence
- Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays
- Testing For SARS-CoV-2: The Day the World Turned its Attention to the Clinical Laboratory
- How should diagnostic kits development adapt quickly in COVID 19-like pandemic models? Pros and cons of sensory platforms used in COVID-19 sensing
- Time-dependent changes in the seroprevalence of COVID-19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID-19
- Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients
- Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays
- Trends and Innovations in Biosensors for COVID-19 Mass Testing
- Comparison of the Elecsys® Anti-SARS-CoV-2 immunoassay with the EDI™ enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma
- Immune response to SARS-CoV-2 in health care workers following a COVID-19 outbreak: A prospective longitudinal study
- Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection
- Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
- Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation
- Antibody response using six different serological assays in a completely PCR-tested community after a COVID-19 outbreak - the CoNAN study
- Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020
- Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by 4 automated immunoassays and 3 ELISAs
- Comparison of the diagnostic sensitivity of SARS-CoV-2 nucleoprotein and glycoprotein-based antibody tests
- Clinical Performance of the Elecsys Electrochemiluminescent Immunoassay for the Detection of SARS-CoV-2 Total Antibodies
- Clinical Performance of the Roche SARS-CoV-2 Serologic Assay
- Evaluation of Three Commercial Automated Assays for the Detection of anti-SARS-CoV-2 Antibodies
- Side by side comparison of three fully automated SARS-CoV-2 antibody assays with a focus on specificity
- Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays
- Evaluation of an electrochemiluminescent SARS-CoV-2 antibody assay
- Multi-platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19
- Evaluation of six commercial mid to high volume antibody and six point of care lateral flow assays for detection of SARS-CoV-2 antibodies
- EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA)
- High-throughput immunoassays for SARS-CoV-2 – considerable differences in performance when comparing three methods
- Diagnostic accuracy of six commercial SARS-CoV-2 IgG/total antibody assays and identification of SARS-CoV-2 neutralizing antibodies in convalescent sera
- Comparison of SARS-CoV-2 serological tests with different antigen targets
- Comparison of sixteen serological SARS-CoV-2 immunoassays in sixteen clinical laboratories
- Longitudinal analysis of clinical serology assay performance and neutralising antibody levels in COVID19 convalescents
- Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with
- Performance assessment of 11 commercial serological tests for SARS-CoV-2 on hospitalised COVID-19 patients.
- Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys(R) Anti-SARS-CoV-2 immunoassay.
- Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to
- Independent Side-by-Side Validation and Comparison of 4 Serological Platforms for SARS-CoV-2 Antibody Testing.
- Variable Performance in 6 Commercial SARS-CoV-2 Antibody Assays May Affect Convalescent Plasma and Seroprevalence Screening.